VERV - Verve Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

VERV is currently covered by 7 analysts with an average price target of $29.37. This is a potential upside of $20.97 (249.64%) from yesterday's end of day stock price of $8.4.

Verve Therapeutics's activity chart (see below) currently has 8 price targets and 23 ratings on display. The stock rating distribution of VERV is 68.75% BUY and 31.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 19.43 days.

Highest price target for VERV is $35, Lowest price target is $22, average price target is $29.37.

Most recent stock forecast was given by LUCA ISSI from RBC on 28-Feb-2024. First documented stock forecast 12-Jul-2021.

Currently out of the existing stock ratings of VERV, 11 are a BUY (68.75%), 5 are a HOLD (31.25%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

35

$26.6 (316.67%)

35

1 months 16 days ago

0/4 (0%)

$17.04 (94.88%)

Buy

32

$23.6 (280.95%)

29

5 months 5 days ago

0/3 (0%)

$15.25 (91.04%)

Hold

22

$13.6 (161.90%)

22

7 months ago

1/3 (33.33%)

$9 (69.23%)

8

Hold

31

$22.6 (269.05%)

48

8 months 2 days ago

0/2 (0%)

$13.02 (72.41%)

Buy

56

$47.6 (566.67%)

34

1 years 7 months 19 days ago

1/4 (25%)

$14.69 (35.56%)

128

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERV (Verve Therapeutics) average time for price targets to be met?

On average it took 19.43 days on average for the stock forecasts to be realized with a an average price target met ratio 8.33

Which analyst has the current highest performing score on VERV (Verve Therapeutics) with a proven track record?

ETZER DAROUT

Which analyst has the current lower performing score on VERV (Verve Therapeutics) with a proven track record?

WHITNEY IJEM

Which analyst has the most public recommendations on VERV (Verve Therapeutics)?

Etzer Darout works at BMO and has 8 price targets and 6 ratings on VERV

Which analyst is the currently most bullish on VERV (Verve Therapeutics)?

Kostas Biliouris with highest potential upside - $53.6

Which analyst is the currently most reserved on VERV (Verve Therapeutics)?

Etzer Darout with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?